Octarine Bio in a €7.8M series A deal with DSM Venturing, Óskare Capital, The Footprint Fund, EIFO, Unconventional Ventures

Biotech Fashion Health services Manufacturing Pharma

Investments

14 July 2025

Octarine Bio (company)

Biotech Fashion Health services Manufacturing Pharma

Total investments received (USD): 24.5m

Round value (USD): 9.13m

Round investors: Oskare Capital Unconventional Ventures DSM Venturing The Footprint Firm EIFO Ginkgo Bioworks

Industry: Biotech Fashion Health services Manufacturing Pharma

Biotech Fashion Health services Manufacturing Pharma

Investments 23 December 2025

Biotech Food Industry Manufacturing

Investments 17 December 2025

AI (big data) Biotech Health services Manufacturing

Investments 02 December 2025

Electronics Health services Manufacturing

Investments 02 August 2025

AI (big data) Biotech Electronics Hardware Health services Manufacturing Software Services

Investments 01 August 2025